Status:
ACTIVE_NOT_RECRUITING
Genomics of Fibrin Clot Structure in Patients With Constitutional Dysfibrinogenemia
Lead Sponsor:
University Hospital, Clermont-Ferrand
Conditions:
Hereditary Dysfibrinogenemia
Eligibility:
All Genders
18+ years
Brief Summary
Hereditary dysfibrinogenemia results from monoallelic mutation in one of the fibrinogen genes (FGA, FGB, FGG). The spectrum of molecular abnormalities is broad, leading to several subtypes of coagulat...
Eligibility Criteria
Inclusion
- Patient with confirmed hereditary dysfibrinogenemia
- Able to give his/her informed consent to participate
- Affiliated to the French Health insurance
Exclusion
- Refusal to participate
- pregnant and breastfeeding women,
- protected adults (individuals under guardianship by court order),
- adults deprived of their liberty
Key Trial Info
Start Date :
July 28 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2024
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT05233384
Start Date
July 28 2022
End Date
December 1 2024
Last Update
June 18 2024
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU clermont-ferrand
Clermont-Ferrand, France
2
CHU Dijon
Dijon, France
3
CHU de Lille
Lille, France
4
CHU Montpellier
Montpellier, France